Ohning, G V <br/><br/>
Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jun 2000 
 - 701-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2000.00774.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Ulcer Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Gastric Acid--metabolism<br/>Gastric Acidity Determination<br/>Helicobacter Infections--complications<br/>Helicobacter pylori--pathogenicity<br/>Humans<br/>Male<br/>Middle Aged<br/>Omeprazole--analogs & derivatives<br/>Peptones--pharmacology<br/>Rabeprazole